AstraZeneca’s breast cancer drug, Enhertu, added to national insurance scheme in China
CHINA—China’s National Healthcare Security Administration has announced that Enhertu, a leading...
Read MoreSelect Page
Nov 29, 2024
CHINA—China’s National Healthcare Security Administration has announced that Enhertu, a leading...
Read MoreNov 28, 2024
CHINA—Kingworld Medicines Group Limited, a prominent player in healthcare distribution, has...
Read MoreAug 7, 2024
CHINA—Scientists at Shanghai Jiaotong University School of Medicine (SJTU) have unveiled a...
Read MoreJul 19, 2024
CHINA—Rona Therapeutics, a clinical-stage pioneering platform company specializing in nucleic acid...
Read MoreJul 12, 2024
CHINA—Swedish research-based biopharma company BioArctic’s partner Eisai has received...
Read MoreMay 28, 2024
CHINA—A hospital in Anhui province in China has performed the world’s first liver transplant...
Read MoreMay 17, 2024
CHINA – Everest Medicines, a biopharmaceutical company listed in Hong Kong, has launched...
Read MoreMay 16, 2024
CHINA – Jiangsu’s public hospitals have implemented a new policy aimed at diminishing...
Read MoreMay 16, 2024
CHINA – WestGene, a leading biotech company dedicated to mRNA technology, announces the...
Read MoreMay 11, 2024
USA -In a proactive bid to safeguard the nation against critical equipment shortages magnified by...
Read More